Patients with age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV) who had not been treated previously were found to have better control of pigment epithelial detachment ...

Patients with chronic spontaneous urticaria (CSU) experienced improved quality of life and sleep when symptoms were mitigated ...

Hearn Jay Cho, MD, PhD, chief medical officer at the Multiple Myeloma Research Foundation, shared insights on what end points ...

In the KEYNOTE-B96 trial ( NCT05116189 ), weekly paclitaxel with bevacizumab and pembrolizumab (Keytruda; Merck) demonstrated ...

Among adults surveyed, 27.8% (95% CI, 25.7-29.8) received all telemental health care, 21.5% (95% CI, 19.8-23.1) received ...

Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...

Eleanor Perfetto, PhD, explores how most favored nation policy relates to broader drug pricing and cost-effectiveness debates ...

Careful consideration of individual patient factors and thorough consultations are key for pharmacists to maximize their impact on cancer care access and adherence, according to Ryan Haumschild, ...

While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...

Zachary Contreras from Sharp Health Plan explains how managed care organizations can support early adoption of DM-BUP to ...

Nerandomilast, a PDE4B inhibitor, is a new treatment option for IPF, showing better tolerability than nintedanib and ...

Many adults with obstructive hypertrophic cardiomyopathy (oHCM) taking mavacamten experienced new atrial fibrillation or flutter, new-onset heart failure, and frequent acute care use within months of ...